ENO3 and cancer: ENO3, as a member of the human enolase (ENO) family catalyzing the transformation of 2-phosphoglycerate to phosphoenolpyruvate during glycolysis, was reported to inhibit the growth of cancer cells (Kong et al., 2016; Feng et al., 2021).